Evidence map›Paper›PMID 36451898›Full record

ArticleRespiratory medicine case reports2022

Pulmonary hemorrhage in patients receiving anti-platelets- a case series and a suggested therapeutic algorithm.

Ioannis Tomos, Maria Kallieri, Andriana I Papaioannou, Eleni Stagaki, Thomas Raptakis, Anna Karakatsani, Panagiotis Korkonikitas, Effrosyni D Manali, Vagia Karageorgou, Myrto Mplizou and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Ioannis Tomos2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Maria Kallieri2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Andriana I Papaioannou2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Eleni Stagaki2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Thomas Raptakis2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Anna Karakatsani2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Panagiotis KorkonikitasDepartment of Cardiology, "Agia Olga" Hospital, Athens, Greece.
Effrosyni D Manali2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Vagia Karageorgou2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Myrto Mplizou2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Katerina Vlami2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Stelios Loukides2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Spyros Papiris2nd Pulmonary Medicine Department, 'ATTIKON' University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
University General Hospital Attikon · GRAgia Olga Hospital · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antiplatelet therapy including aspirin and thienopyridine agents (such as clopidogrel, prasugrel and ticagrelor) are often used in patients with coronary disease. Pulmonary hemorrhage due to antiplatelet therapy although very rare, when excessive, is a life-threatening event. So far, there is lack of specific guidelines for the management of these patients. We report a case series of 5 patients receiving antiplatelet therapy who were admitted to the hospital due to pulmonary hemorrhage related to antiplatelet therapy. We also propose an algorithm on the management of these patients taking into consideration the balance between thrombotic and bleeding risk and the severity of the hemorrhage.

Indexed as

ADP, Thienopyridine adenosine diphosphateAlgorithmAntiplatelet therapyBAL, Broncho-alveolar lavageCOX-1, Cyclooxygenase-1CT, Computerized tomographyENT, OtolaryngologistHemoptysisLRTI, Lower respiratory tract infectionPulmonary hemorrhage

Identifiers

PMID36451898
PMCPMC9703373
OpenAlexW4309892167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.